The role of the comprehensive complication index in the prediction of tumor-related death in transplanted patients with hepatocellular carcinoma
Authors:
Open Access
- 10 February 2025
- journal article
- research article
- Published by Springer Nature in Updates in Surgery
- Vol. 77 (3) , 705-715
Abstract
Liver transplantation (LT) is the primary treatment for selected patients with hepatocellular carcinoma (HCC). However, HCC-related mortality post-LT remains a significant concern, with up to 10% of cases reported in international series. Identifying risk factors for adverse clinical outcomes is essential. We hypothesized that post-LT HCC-related mortality rates are higher in patients with a high (≥ 42) Comprehensive Complication Index (CCI) calculated at discharge. This study aims to compare post-LT HCC-related mortality rates between two groups of patients with high versus low CCI following LT for HCC. This study included data from seven collaborative European centers. A cohort of 1121 HCC patients transplanted between 2005 and 2019, surviving more than six months post-LT, was analyzed retrospectively. Patients were divided into two groups based on the CCI at discharge: Low-CCI Group (n = 942, 84.0%) and High-CCI Group (n = 179, 16.0%). An inverse probability of treatment weighting (IPTW) approach was applied for analysis. In the post-IPTW cohort, four multivariable logistic regression models with mixed effects identified independent risk factors for HCC-related death, overall death, recurrence, and early recurrence. A CCI score of ≥ 42 emerged as an independent risk factor across all models. Specifically, CCI ≥ 42 was associated with increased odds of HCC-related death (OR = 3.35; P < 0.0001), overall death (OR = 2.63; P < 0.0001), overall recurrence (OR = 2.09; P = 0.001), and early recurrence (OR = 1.88; P = 0.02). A CCI score at discharge should be considered a critical factor for recurrence and HCC-related mortality risk. Incorporating CCI into standard post-LT predictive models may enhance prognostic accuracy for adverse HCC outcomes.Keywords
Funding Information
- Università degli Studi di Roma La Sapienza
This publication has 27 references indexed in Scilit:
- Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrenceCancer Communications, 2023
- The impact of postoperative complications on oncological outcomes of liver transplantation for hepatocellular carcinoma: A competing risk analysisDigestive and Liver Disease, 2023
- Major postoperative complications are associated with early recurrence of hepatocellular carcinoma following hepatectomyLangenbeck's Archives of Surgery, 2022
- The role of the comprehensive complication index for the prediction of survival after liver transplantationUpdates in Surgery, 2020
- Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest‐Risk Hepatocellular Carcinoma PatientsLiver Transplantation, 2020
- The prognostic significance of the comprehensive complication index in patients with gastric cancerSurgery Today, 2019
- Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International, 2018
- Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver TransplantJAMA Oncology, 2017
- Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantationHepatology, 2014
- Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factorsLiver Transplantation, 2010